Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001697878 | SCV000722235 | likely benign | not provided | 2020-08-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000863292 | SCV001003928 | likely benign | Alstrom syndrome | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000606582 | SCV001478706 | likely benign | not specified | 2021-01-07 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000606582 | SCV002070211 | likely benign | not specified | 2021-07-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002377276 | SCV002687260 | likely benign | Cardiovascular phenotype | 2019-05-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |